Search Within

Katie Lynn Thoren

Formats
  1. Journal Article (22)
  2. Meeting Abstract (9)
  3. Review (5)
  4. Book Section (1)
Groups
  1. Department of Medicine (23)
  2. Center for Hematologic Malignancies (22)
  3. Hematologic Malignancies, Division of (22)
  4. Department of Pathology and Laboratory Medicine (20)
  5. Hematologic Malignancies Research (16)
  6. Myeloma (16)

More Groups

People
  1. Carl Landgren (15)
  2. Malin Hultcrantz (12)
  3. Mikhail Roshal (12)
  4. Alexander Lesokhin (11)
  5. Hani Hassoun (11)
  6. Kazunori Murata (11)

More People

Years
  1. 2024 (1)
  2. 2022 (1)
  3. 2021 (9)
  4. 2020 (7)
  5. 2019 (11)
  6. 2018 (4)

More Years

Publications
  1. Blood (7)
  2. Journal of Applied Laboratory Medicine (5)
  3. Clinica Chimica Acta (3)
  4. Biology of Blood and Marrow Transplantation (2)
  5. JAMA Oncology (2)
  6. Best Practice and Research: Clinical Haematology (1)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. Amer Assoc Clinical Chemistry (5)
  3. Elsevier Inc. (5)
  4. Elsevier Science BV (3)
  5. American Association for Clinical Chemistry (2)
  6. American Medical Association (2)

More Publishers

Results (37)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mass spectrometry methods for detecting monoclonal immunoglobulins in multiple myeloma minimal residual disease
    Journal Article

    Thoren, K. L.
    Seminars in Hematology (2018)

    Fulltext@MSK | Save
  • Voxelotor (GBT440) produces interference in measurements of hemoglobin S
    Journal Article

    Rutherford, N. J.; Thoren, K. L.; Shajani-Yi, Z.; Colby, J. M.
    Clinica Chimica Acta (2018)

    Fulltext@MSK | Save
  • Empiric anti-thymocyte globulin (ATG) dosing in ex-vivo CD34-selected myeloablative allogeneic hematopoietic cell transplantation (allo-HCT) may result in ATG overexposure that negatively affects outcomes
    Meeting Abstract

    Scordo, M.; Bhatt, V.; Smith, M.; Thoren, K.; Hilden, P.; Cho, C.; Shah, G. L.; Maloy, M.; Papadopoulos, E. B.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Schòˆder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Cadzin, B. R.; Fox, S. Y.; Gerecitano, J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Baseline metabolic tumor volume is an independent prognostic factor for relapsed and refractory Hodgkin lymphoma patients receiving PET-adapted salvage therapy with brentuximab vedotin and augmented ICE
    Meeting Abstract

    Moskowitz, A. J.; Schòˆder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Optimization and validation of high-resolution mass spectrometry data analysis parameters
    Journal Article

    Colby, J. M.; Thoren, K. L.; Lynch, K. L.
    Journal of Analytical Toxicology (2017)

    Fulltext@MSK | Save
  • Comparison of information-dependent acquisition on a tandem quadrupole TOF vs a triple quadrupole linear ion trap mass spectrometer for broad-spectrum drug screening
    Journal Article

    Thoren, K. L.; Colby, J. M.; Shugarts, S. B.; Wu, A. H. B.; Lynch, K. L.
    Clinical Chemistry (2016)

    Fulltext@MSK | Save